H10.533 Contact blepharoconjunctivitis, bilateral

Name of the Condition

• Contact blepharoconjunctivitis, bilateral

Summary

Contact blepharoconjunctivitis, bilateral, is an inflammatory condition affecting both eyelid margins (blepharitis) and the conjunctiva of both eyes, typically triggered by direct contact with an allergen or irritant. It often presents with redness, irritation, and discharge, with symptoms commonly including eyelid swelling, itching, and a gritty sensation. Onset is linked to exposure to specific substances.

Causes

Contact blepharoconjunctivitis, bilateral, is primarily caused by allergic reactions to substances that come into direct contact with the eyes or eyelids, such as cosmetics, contact lens solutions, or topical medications. Irritants like chemicals, smoke, or environmental pollutants may also contribute. In some cases, underlying sensitivities to materials in eye products or occupational exposures can drive inflammation.

Risk Factors

• Use of contact lenses, especially with improper hygiene or solution sensitivity.
• Exposure to allergens or irritants (e.g., cosmetics, eye drops, workplace chemicals).
• Pre-existing allergic conditions (e.g., atopic dermatitis, allergic rhinitis).
• Frequent use of topical eye medications or cosmetics.
• Occupational exposure to irritants (e.g., dust, fumes).

Symptoms

• Redness and swelling of both eyelid margins.
• Itching, burning, or gritty sensation in both eyes.
• Discharge (watery or mucoid) from both eyes.
• Crusting or scaling along the eyelid margins.
• Increased tearing or sensitivity to light.

Diagnosis

Diagnosis involves a clinical evaluation of both eyes, including assessment of eyelid margins, conjunctival redness, and discharge. A detailed patient history focusing on exposure to potential allergens or irritants (e.g., cosmetics, contact lens solutions) is critical. In some cases, patch testing or allergen-specific testing may be used to identify triggers, though this is not always required for initial diagnosis.

Treatment Options

Treatment typically includes avoiding the identified trigger substance. Topical antihistamines or mast cell stabilizers may reduce itching and inflammation. Artificial tears can alleviate dryness or irritation. For severe cases, short-term use of topical corticosteroids may be considered under medical supervision. Contact lens use should be discontinued until symptoms resolve.

Prognosis and Follow-Up

Prognosis is generally good with avoidance of triggers and appropriate treatment. Symptoms often improve within days to weeks. Follow-up may be recommended to monitor for recurrence or to adjust treatment if symptoms persist. Long-term management focuses on preventing re-exposure to identified allergens or irritants.

Complications

Untreated or recurrent inflammation may lead to chronic eyelid margin changes, such as thickening or scarring. Persistent irritation can increase the risk of secondary infections or corneal involvement. In rare cases, severe allergic reactions may cause vision-threatening complications.

Lifestyle & Prevention

• Identify and avoid known allergens or irritants (e.g., specific cosmetics, contact lens solutions).
• Practice good eyelid hygiene, including gentle cleansing with mild soap and water.
• Use hypoallergenic or preservative-free eye products when possible.
• Ensure proper contact lens hygiene and avoid overnight wear if sensitivity is suspected.
• Wear protective eyewear in environments with potential irritants (e.g., dust, fumes).

When to Seek Professional Help

Seek medical attention if symptoms worsen, persist beyond a week, or involve vision changes (e.g., blurriness, pain). Immediate care is needed for severe swelling, discharge, or signs of infection (e.g., fever, increased redness). Recurrent episodes may require further evaluation to identify underlying triggers.

Tips for Medical Coders

Document the bilateral nature of the condition and any identified triggers (e.g., allergens, irritants) to support code assignment. Ensure clinical notes specify involvement of both eyes, as this distinguishes the code from unilateral or unspecified presentations. Include details on exposure history or testing if available, as these may clarify the diagnosis for coding and billing purposes.